Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220129
Status:
COMPLETED
Last Update Posted:
2009-12-16
First Post:
2005-09-19
Brief Title:
Neoadjuvant Epirubicin Cisplatin and Capecitabine ECX Followed by Definitive Chemoradiation WithWithout Surgery for Squamous Cell Carcinoma of the Oesophagus
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Organization Data
Organization:
Royal Marsden NHS Foundation Trust
Class:
OTHER
Study ID:
2186
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jane Lawrence
Old Organization:
Royal Marsden NHS Foundation Trust